tirzepatide shortage update today The FDA says the Zepbound is over. That's rattling the weight loss industry Mounjaro and Zepbound no longer

Running out of syringes or alcohol swabs mid-protocol creates unnecessary stress

Research-grade peptides, typically sold as lyophilized powder, have different storage expectations and are not assigned BUDs under the same regulatory framework

While the available data on the association between bowel obstruction and GLP-1 medications remains inconsistent, the reports exist and researchers should be aware

This is not a lot

Heat and light can degrade the medication, rendering it less effective

On May 7, 2025, the US District Court for the Northern District of Texas upheld the FDA decision to remove tirzepatide from the shortage list